Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Software Validation in AMD Lab – V 2.0

Posted on By

Analytical Method Development: Software Validation in AMD Lab – V 2.0

SOP for Software Validation Activities in the Analytical Method Development Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/034/2025
Supersedes SOP/AMD/034/2022
Page No. Page 1 of 15
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP describes the validation process for all software systems and computerized instruments used in the Analytical Method Development (AMD) laboratory to ensure they are suitable for their intended use, comply with regulatory guidelines, and safeguard data integrity.

2. Scope

This SOP applies to all analytical software and computerized systems including HPLC, GC, UV-Vis spectrophotometer software (e.g., Empower, LabSolutions), LIMS systems, and standalone or network-based instruments used for method development activities within the AMD department.

3. Responsibilities

  • IT/CSV Team: Leads software validation lifecycle activities, executes testing protocols, maintains audit trails.
  • Analytical Scientist: Defines user requirements and provides functional input during validation phases.
  • QA: Reviews validation documentation and authorizes system release for GMP use.
  • Head – AMD: Approves User Requirement Specifications (URS), oversees validation readiness, and ensures training of users.
See also  Analytical Method Development: Reference Standard Qualification for AMD - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring that all analytical software used in the lab is validated before use and that periodic reviews are performed to maintain compliance.

5. Procedure

5.1 Software Validation Lifecycle

  1. Follow the V-model of validation per GAMP 5 and FDA 21 CFR Part 11.
  2. Phases include:
    • User Requirement Specification (URS)
    • Functional Specification (FS)
    • Design Specification (DS)
    • Installation Qualification (IQ)
    • Operational Qualification (OQ)
    • Performance Qualification (PQ)
  3. Maintain records using Annexure-1: Software Validation Master Checklist.

5.2 User Requirement Specification (URS)

  1. Define specific needs of the AMD lab such as:
    • Peak integration and reporting
    • Audit trails and access control
    • Data export and backup
  2. Document in Annexure-2: URS Template and approve by QA and Head – AMD.

5.3 Qualification Activities (IQ/OQ/PQ)

  1. IQ: Verify installation of software, license keys, operating environment.
  2. OQ: Execute predefined test scripts to confirm:
    • User roles and permission matrix
    • System settings, report formats
    • Electronic signature and audit trail
  3. PQ: Real-time tests using dummy data and simulated workflows from the AMD environment.
  4. Document using Annexure-3: IQ Report, Annexure-4: OQ Report, and Annexure-5: PQ Report.
See also  Analytical Method Development: Deviation Management during Method Development - V 2.0

5.4 Data Integrity & Security Controls

  1. Ensure compliance with ALCOA+ principles:
    • System must maintain unalterable audit trail
    • Access must be password protected
    • Only authorized users can create or delete data
  2. QA to review and sign off Annexure-6: Data Integrity Compliance Checklist.

5.5 Change Management and Periodic Review

  1. All software updates must follow formal change control per SOP/QMS/045/2025.
  2. Periodic review of software validation to be performed annually or post-upgrade.
  3. Track revalidation activities using Annexure-7: Validation Review Log.

6. Abbreviations

  • AMD: Analytical Method Development
  • CSV: Computer System Validation
  • IQ/OQ/PQ: Installation/Operational/Performance Qualification
  • GAMP: Good Automated Manufacturing Practice
  • LIMS: Laboratory Information Management System

7. Documents

  1. Software Validation Master Checklist – Annexure-1
  2. User Requirement Specification Template – Annexure-2
  3. IQ Report – Annexure-3
  4. OQ Report – Annexure-4
  5. PQ Report – Annexure-5
  6. Data Integrity Compliance Checklist – Annexure-6
  7. Validation Review Log – Annexure-7

8. References

  • GAMP 5 – A Risk-Based Approach to Compliant GxP Computerized Systems
  • 21 CFR Part 11 – Electronic Records; Electronic Signatures
  • WHO TRS 1019 Annex 5 – Good Data and Record Management Practices
See also  Analytical Method Development: Training Matrix for AMD Analysts - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Software Validation Master Checklist

Phase Status Date Remarks
URS Completed 01/05/2025 Approved by QA
IQ Completed 03/05/2025 Installation successful

Annexure-2: URS Template

Requirement Description Criticality
Audit Trail Track all user actions High
Data Backup Automatic scheduled backups Medium

Annexure-3: IQ Report

Item Specification Observed Status
Operating System Windows 10 Pro Windows 10 Pro Pass

Annexure-4: OQ Report

Test Expected Observed Status
User Role Access Analyst: No Delete Correct Pass

Annexure-5: PQ Report

Run No. Sample Result Status
PQ-001 Standard Peak Ret Time: 5.88 min Pass

Annexure-6: Data Integrity Compliance Checklist

Parameter Compliant Remarks
Audit Trail Review Enabled Yes Real-time
Access Control Yes Password protected

Annexure-7: Validation Review Log

Review Date System Version Action Taken
10/05/2025 Empower 3 Build 3471 Validated – No revalidation needed

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included PQ testing and GAMP 5 lifecycle model Data integrity audit enhancement
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: API Manufacturing: SOP for Documentation of In-Process Control Results – V 2.0
Next Post: Elixir Department: SOP for Handling Damaged Raw Material Packs – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version